Clinical Trials · NCT04822181
Research Study on Whether Semaglutide Works in People With Non-alcoholic Steatohepatitis (NASH)
- Phase
- Phase 3
- Recruitment status
- Active Not Recruiting
- Sponsor
- Novo Nordisk A/S
- Enrollment
- 1,205
- Start date
- Apr 2021
- Locations
- 557 sites, 39 countries
- Primary endpoint
- Part 1: Resolution of steatohepatitis and no worsening of liver fibrosis (Yes/No)